Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Cancer Research|January 23, 2021
Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast CancerMartina Di Modica, Giorgio Gargari, Viola Regondi, et al.
Plos One|June 10, 2016
Tie2 Expressing Monocytes in the Spleen of Patients with Primary MyelofibrosisRita Campanelli, Gabriela Fois, Paolo Catarsi, et al.
Cancer Cell International|June 26, 2024
Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolutionSerena Mazzucchelli, Lorena Signati, Letizia Messa, et al.
Blood|September 17, 2011
EZH2 mutational status predicts poor survival in myelofibrosisPaola Guglielmelli, Flavia Biamonte, Joannah Score, et al.
Circulation|June 4, 2014
Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced ageMarco Denegri, Rossana Bongianino, Francesco Lodola, et al.
Blood|July 25, 2009
Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality markerGiovanna Piaggio, Vittorio Rosti, Mirko Corselli, et al.
Blood|June 4, 2008
Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemiaAlessandro M Vannucchi, Elisabetta Antonioli, Paola Guglielmelli, et al.
Blood|November 7, 2012
Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutationVittorio Rosti, Laura Villani, Roberta Riboni, et al.
Anticancer Research|February 6, 2009
Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumorsGuido Poggi, Pietro Quaretti, Claudio Minoia, et al.
American Journal of Hematology|January 24, 2018
The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cellsMaria Antonietta Avanzini, Vittorio Abbonante, Paolo Catarsi, et al.
Pageof 8